Saintil Merline 4

What Happened

• Saintil Merline, a director of Symbotic, sold a total of 3,414 shares on March 11, 2026 in open-market/private-sale transactions. The filing reports 3,114 shares sold at $50.76 (proceeds $158,059) and 300 shares sold at $51.42 (proceeds $15,425), for aggregate proceeds of about $173,484. This was a sale (not a purchase) and thus generally not a bullish signal.

Key Details

• Transaction dates and prices: March 11, 2026 — reported lots: 3,114 shares @ $50.76 and 300 shares @ $51.42. Footnotes state the sales were executed in multiple trades at price ranges $50.17–$51.16 and $51.18–$51.65, respectively; the reporting person will provide per-trade breakdown on request.
• Plan/authorization: Executed pursuant to a Rule 10b5-1 trading plan entered August 27, 2025 (Footnote F1).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing timeliness: Form 4 filed March 13, 2026 for transactions on March 11, 2026 — appears timely (no late filing reported).

Context

• Sales executed under 10b5-1 plans are pre-set and often indicate scheduled/automated disposals rather than discretionary insider decisions; they do not, by themselves, imply company outlook. For retail investors, purchases typically carry more direct informational weight than routine sales.